Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Abstract Background Cobalamin (cbl)-related remethylation disorders are a heterogeneous group of inherited disorders comprising the remethylation of homocysteine to methionine and affecting multiple organ systems, most prominently the nervous system and the bone marrow
Individuals who have an allergy to the components of Ozempic or a medical history that includes thyroid cancer, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia Syndrome type 2 (MEN 2), or the potential risk of thyroid tumors are advised against using this medication
Pregnancy Registry Advise patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to VYVANSE during pregnancy [see Use in Specific Populations (8.1)]
PMID 9669294
US$ 24.26
US$ 29.83
US$ 24.06
US$ 29.76
